Ataxia: Clinical Trials

5 trials for Ataxia, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

4 completed, 1 unknown. 5 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 45Completed 4, Unknown 1

Follow Ataxia: new trials by email Literature Review of Ataxia trials Research Report on Ataxia

Trials (filtered) newest first · largest first

All 5 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Effect of Dapagliflozin Administration on the Apoptosis Levels of Patients With Acute Myocardial Infarction
Forxiga® 10 mg Film-Coated Tablet, manufactured by AstraZeneca Pharmaceuticals LP, USA for AstraZeneca Pharmaceuticals Co. Ltd., China imported by PT AstraZeneca Indonesia, Indonesia - Acute Myocardial Infarction (AMI), STEMI - ST Elevation Myocardial Infarction (MI)
Phase 4CompletedYoga Yudhistira402024-09-212025-02-27
C-Trelin Orally Disintegrated(OD) Tablet 5mg in Ataxia Due to Spinocerebellar Degeneration
C-Trelin OD Tab(5mg Taltirelin Hydrate), Placebo - Spinocerebellar Degeneration
Phase 4CompletedHLB Pharmaceutical Co., Ltd.1602019-03-042023-07-24
Response of Individuals With Ataxia-Telangiectasia to Metformin and Pioglitazone
Metformin, Pioglitazone - Ataxia-Telangiectasia
Phase 4CompletedNHS Tayside272016-09-292017-12-04
Status of Growth Hormone/ Insulin-like Growth Factor-1 (GH/IGF-1) Axis and Growth Failure in Ataxia Telangiectasia (AT)
Somatropin, Clonidine, L-Arginin-Hydrochloride, Estradiol valerate - Ataxia Telangiectasia, Growth Failure
Phase 4UnknownJohann Wolfgang Goethe University Hospital242010-01-012010-07-05
Amantadine for Improving Neurologic Symptoms in Ataxia-Telangiectasia
amantadine sulphate - Ataxia, Chorea
Phase 4CompletedSheba Medical Center302008-11-012011-06-28

Narrower conditions

Ataxia Telangiectasia (2)  ·  Chorea (1)  ·  Dystonia (1)  ·  Failure to Thrive (1)  ·  Fatigue (1)  ·  Non-ST Elevated Myocardial Infarction (1)  ·  Parkinsonian Disorders (1)  ·  ST Elevation Myocardial Infarction (1)  ·  Spinocerebellar Ataxias (1)  ·  Spinocerebellar Degenerations (1)

Broader conditions

Brain Diseases (5)  ·  Central Nervous System Diseases (5)  ·  Dyskinesias (5)  ·  Nervous System Diseases (5)  ·  Neurologic Manifestations (5)  ·  Cerebellar Diseases (4)  ·  Congenital, Hereditary, and Neonatal Diseases and Abnormalities (4)  ·  Genetic Diseases, Inborn (4)  ·  Pathological Conditions, Signs and Symptoms (4)  ·  Cardiovascular Diseases (3)  ·  Cerebellar Ataxia (3)  ·  Signs and Symptoms (3)  ·  Vascular Diseases (3)  ·  DNA Repair-Deficiency Disorders (2)

Interventions

Amantadine (1)  ·  Clonidine (1)  ·  Estradiol (1)  ·  Growth Hormone (1)  ·  Human Growth Hormone (1)  ·  Metformin (1)  ·  Pioglitazone (1)  ·  TA 0910 (1)  ·  dapagliflozin (1)

Sponsors

HLB Pharmaceutical Co., Ltd. (1)  ·  Johann Wolfgang Goethe University Hospital (1)  ·  NHS Tayside (1)  ·  Sheba Medical Center (1)  ·  Yoga Yudhistira (1)

Countries

Germany (1)  ·  Indonesia (1)  ·  Israel (1)  ·  South Korea (1)  ·  United Kingdom (1)

Top investigators

Ahmad Yasa MD (1)  ·  Andreea Nissenkorn, MD (1)  ·  Ewan Pearson, MD PhD (1)  ·  Seong-beom Koh (1)  ·  Stefan Zielen, Prof. Dr. (1)  ·  Yoga Yudhistira MD (1)

Results publications

PMID 22550086